BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 29 filers reported holding BIOLINERX LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,887 | -23.2% | 175,762 | -32.7% | 0.00% | – |
| Q2 2023 | $416,257 | +82.8% | 260,976 | +1.6% | 0.00% | – |
| Q1 2023 | $227,753 | +52.6% | 256,912 | +1.6% | 0.00% | – |
| Q4 2022 | $149,242 | -38.6% | 252,952 | -3.7% | 0.00% | – |
| Q3 2022 | $243,000 | -24.8% | 262,559 | +4.1% | 0.00% | – |
| Q2 2022 | $323,000 | -30.4% | 252,184 | -7.1% | 0.00% | – |
| Q1 2022 | $464,000 | -12.6% | 271,535 | +4.4% | 0.00% | – |
| Q4 2021 | $531,000 | -19.5% | 260,166 | +8.3% | 0.00% | – |
| Q3 2021 | $660,000 | +3.6% | 240,128 | +5.9% | 0.00% | – |
| Q2 2021 | $637,000 | -42.7% | 226,822 | -43.1% | 0.00% | – |
| Q1 2021 | $1,112,000 | -39.7% | 398,412 | -45.6% | 0.00% | – |
| Q4 2020 | $1,845,000 | +46.4% | 732,191 | -4.7% | 0.00% | – |
| Q3 2020 | $1,260,000 | +30.4% | 768,335 | +36.0% | 0.00% | – |
| Q2 2020 | $966,000 | +111.4% | 565,114 | +64.3% | 0.00% | – |
| Q1 2020 | $457,000 | -20.7% | 343,909 | +34.3% | 0.00% | – |
| Q4 2019 | $576,000 | +50.0% | 255,987 | +76.1% | 0.00% | – |
| Q3 2019 | $384,000 | – | 145,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 270,665 | $463,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $47,000 | 0.05% |
| Cutter & CO Brokerage, Inc. | 18,667 | $32,000 | 0.01% |
| Opaleye Management Inc. | 16,667 | $29,000 | 0.01% |
| Apollon Wealth Management, LLC | 56,410 | $96,000 | 0.01% |
| Sandy Cove Advisors, LLC | 3,597 | $6,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 104,032 | $178,000 | 0.00% |
| Thomasville National Bank | 10,000 | $17,000 | 0.00% |
| Geneos Wealth Management Inc. | 32,950 | $56,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 14,600 | $24,000 | 0.00% |